<p>Dr. Daniel Curran leads Takeda’s efforts to unlock innovation and deliver transformative medicines in a variety of rare-disease areas. Dan embraces learning from, collaborating with, and meeting members of the rare disease community in an effort to produce treatments that result in better health and a brighter future for rare.</p>
<ul><li>2:02 How rare disease is defined at Takeda</li>
<li>4:10 Rare disease units at Takeda</li>
<li>5:23 How Takeda economically justifies half of their pipeline being rare disease drugs</li>
<li>9:06 The price of rare disease drugs is too high</li>
<li>12:15 Why rare disease efforts are often associated with hematology</li>
<li>14:57 What Dr. Curran enjoys about leading Takeda's rare genetics and hematology therapeutic unit</li>
<li>16:42 Dr. Curran's professional journey</li>
<li>20:50 Takeda's choice to support n-Lorem</li>
</ul>
<br>

Dr. Daniel Curran leads Takeda’s efforts to unlock innovation and deliver transformative medicines in a variety of rare-disease areas. Dan embraces learning from, collaborating with, and meeting members of the rare disease community in an effort to produce treatments that result in better health and a brighter future for rare. 2:02 How rare disease is defined at Takeda 4:10 Rare disease units at Takeda 5:23 How Takeda economically justifies half of their pipeline being rare disease drugs 9:06 The price of rare disease drugs is too high 12:15 Why rare disease efforts are often associated with hematology 14:57 What Dr. Curran enjoys about leading Takeda's rare genetics and hematology therapeutic unit 16:42 Dr. Curran's professional journey 20:50 Takeda's choice to support n-Lorem

Better Health, Brighter Future for Rare with Dan Curran

Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. 

n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. 

The podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crroke, who is the Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.

Science

Medicine

Health & Fitness

Education

Life Sciences

Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. The podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crroke, who is the Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.

Share Better Health, Brighter Future for Rare with Dan Curran

Sign up to save your podcasts

Better Health, Brighter Future for Rare with Dan Curran

Better Health, Brighter Future for Rare with Dan Curran

More shows like Patient Empowerment Program: A Rare Disease Podcast

This American Life

Embedded

The Daily

Crime Junkie

The Readout Loud

The Weekly Show with Jon Stewart

BioSpace